169 related articles for article (PubMed ID: 25560177)
21. The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance.
Di Carlo E; D'Antuono T; Pompa P; Giuliani R; Rosini S; Stuppia L; Musiani P; Sorrentino C
Clin Cancer Res; 2009 May; 15(9):2979-87. PubMed ID: 19366834
[TBL] [Abstract][Full Text] [Related]
22. NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8(+) T cells.
Whitman E; Barber A
Mol Immunol; 2015 Feb; 63(2):268-78. PubMed ID: 25089028
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of pro-tumorigenic effect of BMP-6: neovascularization involving tumor-associated macrophages and IL-1a.
Kwon SJ; Lee GT; Lee JH; Iwakura Y; Kim WJ; Kim IY
Prostate; 2014 Feb; 74(2):121-33. PubMed ID: 24185914
[TBL] [Abstract][Full Text] [Related]
24. Expression of NF-κB-related proteins and their modulation during TNF-α-provoked apoptosis in prostate cancer cells.
Rodríguez-Berriguete G; Fraile B; Paniagua R; Aller P; Royuela M
Prostate; 2012 Jan; 72(1):40-50. PubMed ID: 21520161
[TBL] [Abstract][Full Text] [Related]
25. Regulation of cytokine signaling and T-cell recruitment in the aging mouse brain in response to central inflammatory challenge.
Xu YZ; Nygård M; Kristensson K; Bentivoglio M
Brain Behav Immun; 2010 Jan; 24(1):138-52. PubMed ID: 19765643
[TBL] [Abstract][Full Text] [Related]
26. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
[TBL] [Abstract][Full Text] [Related]
27. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
[TBL] [Abstract][Full Text] [Related]
28. Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation.
Wong VK; Zhou H; Cheung SS; Li T; Liu L
J Cell Biochem; 2009 May; 107(2):303-15. PubMed ID: 19301261
[TBL] [Abstract][Full Text] [Related]
29. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
Huber MA; Azoitei N; Baumann B; Grünert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T
J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694
[TBL] [Abstract][Full Text] [Related]
30. The estrogen receptor signaling pathway activated by phthalates is linked with transforming growth factor-β in the progression of LNCaP prostate cancer models.
Lee HR; Hwang KA; Choi KC
Int J Oncol; 2014 Aug; 45(2):595-602. PubMed ID: 24858230
[TBL] [Abstract][Full Text] [Related]
31. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
32. Regulation of cell survival by resveratrol involves inhibition of NF kappa B-regulated gene expression in prostate cancer cells.
Benitez DA; Hermoso MA; Pozo-Guisado E; Fernández-Salguero PM; Castellón EA
Prostate; 2009 Jul; 69(10):1045-54. PubMed ID: 19301309
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori VacA activates NF-kappaB in T cells via the classical but not alternative pathway.
Takeshima E; Tomimori K; Takamatsu R; Ishikawa C; Kinjo F; Hirayama T; Fujita J; Mori N
Helicobacter; 2009 Aug; 14(4):271-9. PubMed ID: 19674131
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Egr-1 by siRNA in prostate carcinoma cell lines is associated with decreased expression of AP-1 and NF-κB.
Parra E; Ferreira J; Saenz L
Int J Mol Med; 2011 Nov; 28(5):847-53. PubMed ID: 21743958
[TBL] [Abstract][Full Text] [Related]
36. Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice.
Santana AC; Degaspari S; Catanozi S; Dellê H; de Sá Lima L; Silva C; Blanco P; Solez K; Scavone C; Noronha IL
Nephrol Dial Transplant; 2013 May; 28(5):1140-9. PubMed ID: 23345625
[TBL] [Abstract][Full Text] [Related]
37. Receptor for advanced glycation end-products signals through Ras during tobacco smoke-induced pulmonary inflammation.
Reynolds PR; Kasteler SD; Schmitt RE; Hoidal JR
Am J Respir Cell Mol Biol; 2011 Aug; 45(2):411-8. PubMed ID: 21131443
[TBL] [Abstract][Full Text] [Related]
38. Intracellular JNK, p38 MAPK and NF-kappaB regulate IL-25 induced release of cytokines and chemokines from costimulated T helper lymphocytes.
Wong CK; Li PW; Lam CW
Immunol Lett; 2007 Oct; 112(2):82-91. PubMed ID: 17719653
[TBL] [Abstract][Full Text] [Related]
39. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
[TBL] [Abstract][Full Text] [Related]
40. Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway.
Shaikh IA; Brown I; Schofield AC; Wahle KW; Heys SD
Prostate; 2008 Nov; 68(15):1635-46. PubMed ID: 18668525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
